Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-28

Clinical Trial Update: Use of Propranolol to Reduce FDG Uptake in Brown Adipose Tissue in Pediatric Cancer Patients PET Scans

View source ↗

Summary

A completed pediatric cancer trial evaluated the use of propranolol to reduce FDG uptake in brown adipose tissue during PET scans, potentially improving scan in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propranolol (propranolol)

Snippet

Sponsor: Lars Wagner | Conditions: Pediatric Cancer | Status: COMPLETED